Sources
Story Timeline
•Latest version
Bayer Faces $1.56B Verdict in Roundup Trial, Halts Drug Study, and Pays $165M Over PCBs in Seattle School
Bristol-Myers' $5B Lung Cancer Drug Approved; Bayer Faces $1.56B Verdict, Setbacks
Bristol-Myers' Lung Cancer Drug Approved; Bayer Faces Setbacks, Ordered to Pay $1.56B, Shares Plunge, Blood-Thinning Drug Trial Halted
•Original version
Missouri Jury Orders Bayer to Pay $1.56 Billion in US Trial Over Roundup Weedkiller; Casts Doubt on Bristol Myers' $5 Billion Drug